Natera, Inc. (NTRA)
NASDAQ • Healthcare
Last close at November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Natera, Inc. currently loses $8.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Natera’s preliminary third fiscal quarter of 2026 results paired a revenue beat with an EPS miss, as revenue of $794.0 million topped the $707.5 million estimate, +12.2%, while EPS of -$0.42 trailed the -$0.28 estimate by -$0.14, with the company reporting on November 5, 2026. Revenue rose ~34% to about $794.0 million (up from roughly $592.2 million a year ago), led by Insurance carriers, which increased ~36% to about $705.1 million, while Laboratory partners grew roughly 70% to about $37.7 million. Profitability tracked with a gross margin of roughly 65% and an operating margin of -8.6%, as operating income was -$68.3 million. Net income improved ~32% year over year to about -$59.9 million (from roughly -$87.5 million), and EPS improved ~34% from -$0.64 a year ago to -$0.42. The quarter generated operating cash flow of about $43.9 million. For the next period, consensus calls for EPS of -$0.11 on revenue of $749.5 million.
About Natera, Inc.
Natera, Inc. (NASDAQ: NTRA) develops genetic testing and molecular monitoring products for healthcare, operating in diagnostics and research, with $2.3 billion in revenue in FY2025. Its menu spans reproductive health, oncology, and transplant testing, pairing laboratory-developed assays with direct sales and partner distribution on a global basis.
Today's Snapshot
The day ended with NTRA 5.7% lower at 273.40, while its sector was flat. Trading was lighter than usual, with volume about two-thirds of its usual level. Natera’s management targeted more than $6 billion by 2029.
Trading Volume
Below 10d avg (2.0M)
1.3M
vs S&P 500 Today
Underperforming Market
-2.21%
Updated: November 20, 2026 at 21:23 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$291.25 - $350.42Sell
- RSI (14)26.15Buy
- Stochastic %K (14, 3, 3)6.06Buy
- MACD Level (12, 26)-28.90Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.